Ifm Investors Pty LTD Abiomed Inc Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	BUY	$242.49 - $301.46 $123,669 - $153,744	510 Added 6.9%	7,903 $1.94 Million
Q2 2022 Jul 15, 2022	BUY	$224.73 - $338.64 $102,027 - $153,742	454 Added 6.54%	7,393 $1.83 Million
Q1 2022 Apr 13, 2022	BUY	$277.25 - $366.29 $285,567 - $377,278	1,030 Added 17.43%	6,939 $2.3 Million
Q4 2021 Jan 18, 2022	SELL	$300.63 - $371.35 $33,670 - $41,591	-112 Reduced 1.86%	5,909 $2.12 Million
Q2 2021 Jul 16, 2021	BUY	$262.71 - $351.17 $303,955 - $406,303	1,157 Added 23.79%	6,021 $1.88 Million
Q1 2021 May 05, 2021	BUY	$285.92 - $355.13 $185,848 - $230,834	650 Added 15.42%	4,864 $1.55 Million
Q4 2020 Jan 13, 2021	BUY	$251.88 - $324.2 $134,503 - $173,122	534 Added 14.51%	4,214 $1.37 Million
Q3 2020 Oct 16, 2020	BUY	$255.22 - $317.0 $98,770 - $122,679	387 Added 11.75%	3,680 $1.02 Million
Q2 2020 Jul 13, 2020	SELL	$141.4 - $257.09 $166,286 - $302,337	-1,176 Reduced 26.31%	3,293 $795,000
Q1 2020 Apr 09, 2020	SELL	$130.51 - $196.01 $15,791 - $23,717	-121 Reduced 2.64%	4,469 $666,000
Q4 2019 Jan 13, 2020	SELL	$159.31 - $223.54 $3,026 - $4,247	-19 Reduced 0.41%	4,590 $783,000
Q3 2019 Nov 01, 2019	BUY	$175.89 - $279.23 $216,344 - $343,452	1,230 Added 36.4%	4,609 $820,000
Q2 2019 Jul 16, 2019	BUY	$250.96 - $284.94 $181,695 - $206,296	724 Added 27.27%	3,379 $880,000
Q1 2019 Apr 18, 2019	BUY	$276.39 - $362.25 $46,986 - $61,582	170 Added 6.84%	2,655 $758,000
Q4 2018 Jan 23, 2019	BUY	$281.08 - $444.25 $78,140 - $123,501	278 Added 12.6%	2,485 $808,000
Q3 2018 Oct 22, 2018	BUY	$354.53 - $449.75 $119,831 - $152,015	338 Added 18.08%	2,207 $993,000
Q2 2018 Jul 09, 2018	BUY	$278.07 - $446.21 $519,712 - $833,966	1,869 New	1,869 $765,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account